Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,729 | 48,366 | 53,568 | 120,898 | 45,053 |
| Marketable Securities | 53,636 | 47,540 | 64,115 | 43,848 | 40,977 |
| Receivables | 2,342 | 5,694 | 6,117 | 8,985 | 3,325 |
| Inventories | 221 | 7 | N/A | N/A | 1,305 |
| Other current assets | 12 | 152 | 210 | 218 | 79 |
| TOTAL | $92,669 | $104,156 | $125,391 | $175,370 | $92,263 |
| Non-Current Assets | |||||
| PPE Net | 9,390 | 9,395 | 9,546 | 9,613 | 9,602 |
| Investments And Advances | 33,744 | 41,599 | 41,295 | 4,539 | 9,603 |
| Other Non-Current Assets | 841 | 222 | 2,027 | 1,970 | 2,041 |
| TOTAL | $43,975 | $51,216 | $52,868 | $16,122 | $21,246 |
| Total Assets | $136,644 | $155,372 | $178,259 | $191,492 | $113,509 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,530 | 6,497 | 6,464 | 4,727 | 2,997 |
| Accounts payable and accrued liabilities | 18,954 | 17,053 | 18,432 | 15,308 | 13,431 |
| Accrued Expenses | 19,409 | 15,624 | 12,699 | 11,871 | 12,329 |
| TOTAL | $74,173 | $75,342 | $74,836 | $69,237 | $58,937 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,469 | 15,114 | 16,750 | 18,379 | 19,999 |
| Deferred Revenues | 300 | 7,300 | 8,484 | 8,686 | 1,717 |
| TOTAL | $16,287 | $17,976 | $19,656 | $21,623 | $30,496 |
| Total Liabilities | $90,460 | $93,318 | $94,492 | $90,860 | $89,433 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 98,928 | 98,717 | 98,606 | 98,405 | 80,428 |
| Common Shares | 989 | 987 | 984 | 984 | 804 |
| Retained earnings | -674,940 | -656,494 | -631,843 | -612,300 | -597,166 |
| Other shareholders' equity | -452 | -476 | -243 | -17 | -15 |
| TOTAL | $46,184 | $62,054 | $83,767 | $100,632 | $24,076 |
| Total Liabilities And Equity | $136,644 | $155,372 | $178,259 | $191,492 | $113,509 |